Quarterly report pursuant to Section 13 or 15(d)

Net loss per share (Tables)

v3.21.1
Net loss per share (Tables)
3 Months Ended
Mar. 31, 2021
Net loss per share [Abstract]  
Anti-dilutive Securities Excluded from Computation of Net Loss per Share
The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the three month periods ended presented below:
 
   
March 31,
 
   
2021
   
2020
 
Series A Warrants and Series B Warrants
   
7,374,172
     
 
Stock options
   
1,818,612
     
1,029,781
 
Restricted stock awards
   
4,474
     
 
Former Rexahn warrants
   
66,538
     
 
Former Rexahn options
   
123